Back to ALPMY
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Upcoming Catalysts
What are catalysts?Competitive Landscape
0 competitors in Progressive Metastatic Prostate Cancer
View Full LandscapeDrug Information
Target Indication
Progressive Metastatic Prostate Cancer
Clinical Trial
NCT02294461Last updated: 12/24/2025
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts